The First Biopharmaceutical Characterization Laboratory in ASEAN

BPCL Team

Advancing Science Through Strategic Collaboration 

The biopharmaceutical industry has seen rapid growth in the past few years, which has only intensified with the COVID-19 pandemic. In response to the rising demand for biopharmaceutical drugs, Biopharmaceutical Characterization Laboratory (BPCL) plays a pivotal role in ensuring the safety and efficacy of vaccines, pharmaceuticals, biologics, or biosimilars. With their skilled expertise, BPCL provides comprehensive services from research and product development to characterization, quality control testing, and clinical trial development.

All of the methods in BPCL are specifically developed or adapted to meet the product requirements and international standards. Please contact us below if you are interested to engage BPCL one-stop services for biopharmaceutical and drug development research, including:

- Proteins Characterization
- Viral Characterization
- DNA/RNA Characterization
- Microbial & Cell Culture Characterization

Enquire Our Full Suite Of Services Now 

Service Capabilities

BPCL provides One-Stop Services such as Protein Characterization, Microbial & Cell Culture Characterization, Viral Characterization, DNA and RNA Characterization, including analytical chemistry, cell culture and microbiology, DNA & RNA analysis, stability studies, bioanalysis, virology, and protein & peptide analysis in compliance with ISO/IEC 17025, GLP and/or GMP, where appropriate.

Shimadzu Instruments Use By BPCL

Shimadzu offers state-of-art equipment and advanced technologies to support BPCL’s service capabilities. This includes LCMS-Triple Quadrupole, LCMS-QTOF, HPLC, UV-Vis Spectrometer, and MALDI-TOF-MS* etc., which deliver reliable and robust results with a short turnaround time.

*This product may not be available in your country. Please contact your local Shimadzu representative for more information.

 

Protein Characterization

Photo Gallery

Click on the image to view more photos

Top of This Page